NCT00810459

Brief Summary

The objective of this study (Part II) will be to compare the performance of the Trilogy device and a conventional ventilator (participant's current device). Both devices will be set to the participants' current mode and prescription settings.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
6

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Mar 2008

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

March 10, 2008

Completed
9 months until next milestone

First Submitted

Initial submission to the registry

December 17, 2008

Completed
1 day until next milestone

First Posted

Study publicly available on registry

December 18, 2008

Completed
1 month until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 26, 2009

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

January 26, 2009

Completed
12 years until next milestone

Results Posted

Study results publicly available

February 3, 2021

Completed
Last Updated

February 3, 2021

Status Verified

January 1, 2021

Enrollment Period

11 months

First QC Date

December 17, 2008

Results QC Date

October 12, 2020

Last Update Submit

January 14, 2021

Conditions

Outcome Measures

Primary Outcomes (2)

  • Comparable Level of Gas Exchange (Measured as Partial Pressure of Carbon Dioxide (CO2) in Arterial, Venous or Capillary Blood)

    Comparable level of gas exchange (measured as partial pressure of CO2 in arterial, venous or capillary blood)

    After one hour of ventilator use

  • Comparable Level of Gas Exchange for Peripheral Capillary Oxygen Saturation (SpO^2)

    Comparable level of gas exchange for SpO\^2

    After one hour of ventilator use

Secondary Outcomes (3)

  • Heart Rate

    60 minutes

  • Minute Ventilation

    60 minutes

  • Tidal Volume

    60 minutes

Study Arms (2)

Trilogy ventilator

EXPERIMENTAL

Trilogy ventilator

Device: Trilogy Ventilator

Standard of Care

ACTIVE COMPARATOR

Participants currently prescribed ventilator

Device: Standard of Care

Interventions

Exposure to one hour on the Trilog ventilator

Trilogy ventilator

Exposure of one hour on the Participants prescribed ventilator

Standard of Care

Eligibility Criteria

Age1 Year - 18 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64)

You may qualify if:

  • Age \> 1years of age; \< 18 years of age
  • Greater than 5 kg
  • Considered clinically stable, with low flow oxygen requirements less than 15 LPM (or FIO2 less than 60 %) and PEEP no greater than 10 cm H2O
  • Requiring mechanical ventilation through nasal/facial mask, tracheostomy or endotracheal tube (ET Tube)

You may not qualify if:

  • Clinically unstable, i.e.,
  • Acute Respiratory Failure
  • Participants with refractory hypotension defined as systolic blood pressure less than 90 mm Hg despite inotropic agents)
  • Uncontrolled cardiac ischemia or arrhythmias
  • or as otherwise determined inappropriate for the study as determined by the investigator
  • Patients suffering from metastatic or terminal cancer and patients with do-not-resuscitate orders
  • Pregnancy

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of Manitoba

Winnipeg, Manitoba, Canada

Location

MeSH Terms

Conditions

Respiratory Insufficiency

Condition Hierarchy (Ancestors)

Respiration DisordersRespiratory Tract Diseases

Results Point of Contact

Title
Jeff Jasko
Organization
Philips

Study Officials

  • Steven Mink, MD

    University of Manitoba

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
No
Restrictive Agreement
No

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Purpose
TREATMENT
Intervention Model
CROSSOVER
Sponsor Type
INDUSTRY
Responsible Party
SPONSOR

Study Record Dates

First Submitted

December 17, 2008

First Posted

December 18, 2008

Study Start

March 10, 2008

Primary Completion

January 26, 2009

Study Completion

January 26, 2009

Last Updated

February 3, 2021

Results First Posted

February 3, 2021

Record last verified: 2021-01

Locations